Jae Hung Jung

Yonsei University, University of Minnesota

Papers

14

Total Citations

725

H-Index

12

About

Jae Hung Jung is a leading urologic surgeon and researcher whose work has fundamentally shaped the surgical management of prostate cancer and benign prostatic hyperplasia (BPH). His landmark Cochrane systematic reviews comparing laparoscopic and robot-assisted radical prostatectomy to open surgery have been cited over 350 times, providing the highest level of evidence that robotic approaches reduce blood loss and hospital stays while maintaining oncologic outcomes. Jung pioneered the study of Retzius-sparing robotic prostatectomy, demonstrating its potential to improve early continence recovery. His research on extended pelvic lymph node dissection established standards for high-risk prostate cancer staging. Beyond oncology, Jung has advanced minimally invasive BPH treatments, including aquablation therapy. His innovative work includes simultaneous robot-assisted bilateral partial nephrectomy and radical prostatectomy for synchronous cancers, and he has explored perioperative probiotics to reduce complications in colorectal surgery. With over 650 total citations and multiple Cochrane reviews, Jung’s evidence-based contributions have directly influenced international surgical guidelines and improved outcomes for men with urologic cancers.

Research Focus

Key Achievements

12
H-Index
14
Papers
725
Total Citations
52
Avg Citations/Paper
🏆 Most Cited Paper
Laparoscopic and robotic-assisted versus open radical prostatectomy for the treatment of localised prostate cancer
233 citations · 2017
📈 Most Prolific Year: 2020 (3 Papers)
🤝 Key Collaborators: 34
🏛 Institutions: Yonsei University, University of Minnesota

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago